SNOA Annual Total Long Term Liabilities
$4.88 M
+$347.00 K+7.65%
31 March 2024
Summary:
As of January 23, 2025, SNOA annual total long term liabilities is $4.88 million, with the most recent change of +$347.00 thousand (+7.65%) on March 31, 2024. During the last 3 years, it has fallen by -$662.00 thousand (-11.94%). SNOA annual total long term liabilities is now -11.94% below its all-time high of $5.55 million, reached on March 31, 2021.SNOA Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SNOA Quarterly Long Term Liabilities
$5.02 M
+$77.00 K+1.56%
30 September 2024
Summary:
As of January 23, 2025, SNOA quarterly total long term liabilities is $5.02 million, with the most recent change of +$77.00 thousand (+1.56%) on September 30, 2024. Over the past year, it has increased by +$172.00 thousand (+3.54%). SNOA quarterly long term liabilities is now -22.01% below its all-time high of $6.44 million, reached on September 30, 2012.SNOA Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SNOA Long Term Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +7.7% | +3.5% |
3 y3 years | -11.9% | +10.7% |
5 y5 years | +1227.2% | +10.7% |
SNOA Long Term Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -11.9% | +12.8% | at high | +16.8% |
5 y | 5-year | -11.9% | +1227.2% | -9.4% | +345.0% |
alltime | all time | -11.9% | +4260.7% | -22.0% | >+9999.0% |
Sonoma Pharmaceuticals Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $5.02 M(+1.6%) |
June 2024 | - | $4.95 M(+1.3%) |
Mar 2024 | $4.88 M(+7.6%) | $4.88 M(+0.7%) |
Dec 2023 | - | $4.85 M(+2.8%) |
Sept 2023 | - | $4.72 M(+2.4%) |
June 2023 | - | $4.61 M(+1.6%) |
Mar 2023 | $4.54 M(+4.8%) | $4.54 M(+2.3%) |
Dec 2022 | - | $4.43 M(+0.5%) |
Sept 2022 | - | $4.41 M(+1.6%) |
June 2022 | - | $4.34 M(+0.4%) |
Mar 2022 | $4.33 M(-21.9%) | $4.33 M(+0.6%) |
Dec 2021 | - | $4.30 M(+0.3%) |
Sept 2021 | - | $4.29 M(+0.5%) |
June 2021 | - | $4.27 M(-23.1%) |
Mar 2021 | $5.55 M(+31.8%) | $5.55 M(+172.9%) |
Dec 2020 | - | $2.03 M(+0.9%) |
Sept 2020 | - | $2.01 M(+13.8%) |
June 2020 | - | $1.77 M(-57.9%) |
Mar 2020 | $4.21 M(+1043.5%) | $4.21 M(+272.7%) |
Dec 2019 | - | $1.13 M(-5.0%) |
Sept 2019 | - | $1.19 M(-7.1%) |
June 2019 | - | $1.28 M(+247.6%) |
Mar 2019 | $368.00 K(-40.5%) | $368.00 K(-3.2%) |
Dec 2018 | - | $380.00 K(-21.8%) |
Sept 2018 | - | $486.00 K(-6.9%) |
June 2018 | - | $522.00 K(-15.7%) |
Mar 2018 | $619.00 K(-16.4%) | $619.00 K(-12.3%) |
Dec 2017 | - | $706.00 K(-10.2%) |
Sept 2017 | - | $786.00 K(-5.5%) |
June 2017 | - | $832.00 K(+12.4%) |
Mar 2017 | $740.00 K(+560.7%) | $740.00 K(-16.9%) |
Dec 2016 | - | $891.00 K(+1682.0%) |
Sept 2016 | - | $50.00 K(+31.6%) |
June 2016 | - | $38.00 K(-66.1%) |
Mar 2016 | $112.00 K | $112.00 K(-40.1%) |
Dec 2015 | - | $187.00 K(-28.9%) |
Sept 2015 | - | $263.00 K(-22.4%) |
Date | Annual | Quarterly |
---|---|---|
June 2015 | - | $339.00 K(-17.9%) |
Mar 2015 | $413.00 K(-64.3%) | $413.00 K(-15.2%) |
Dec 2014 | - | $487.00 K(-13.5%) |
Sept 2014 | - | $563.00 K(-28.6%) |
June 2014 | - | $788.00 K(-31.8%) |
Mar 2014 | $1.16 M(-65.6%) | $1.16 M(-24.2%) |
Dec 2013 | - | $1.53 M(-41.2%) |
Sept 2013 | - | $2.60 M(-19.0%) |
June 2013 | - | $3.20 M(-4.6%) |
Mar 2013 | $3.36 M(-15.2%) | $3.36 M(-1.4%) |
Dec 2012 | - | $3.40 M(-47.2%) |
Sept 2012 | - | $6.44 M(+80.5%) |
June 2012 | - | $3.57 M(-9.8%) |
Mar 2012 | $3.96 M(+55.3%) | $3.96 M(-10.7%) |
Dec 2011 | - | $4.43 M(+20.0%) |
Sept 2011 | - | $3.69 M(-6.5%) |
June 2011 | - | $3.95 M(+54.9%) |
Mar 2011 | $2.55 M(+481.7%) | $2.55 M(-8.2%) |
Dec 2010 | - | $2.77 M(+21.1%) |
Sept 2010 | - | $2.29 M(+2.3%) |
June 2010 | - | $2.24 M(+411.4%) |
Mar 2010 | $438.00 K(-12.2%) | $438.00 K(-52.8%) |
Dec 2009 | - | $928.00 K(-40.7%) |
Sept 2009 | - | $1.56 M(-21.7%) |
June 2009 | - | $2.00 M(+300.2%) |
Mar 2009 | $499.00 K(-32.0%) | $499.00 K(-11.1%) |
Dec 2008 | - | $561.00 K(-7.1%) |
Sept 2008 | - | $604.00 K(-6.8%) |
June 2008 | - | $648.00 K(-11.7%) |
Mar 2008 | $734.00 K(-63.6%) | $734.00 K(-41.1%) |
Dec 2007 | - | $1.25 M(-20.4%) |
Sept 2007 | - | $1.57 M(-21.9%) |
June 2007 | - | $2.00 M(-0.5%) |
Mar 2007 | $2.02 M(+702.8%) | $2.02 M(-17.9%) |
Dec 2006 | - | $2.45 M(-14.0%) |
Sept 2006 | - | $2.85 M(+1036.3%) |
Mar 2006 | $251.00 K(-51.7%) | $251.00 K(-51.7%) |
Mar 2005 | $520.00 K | $520.00 K |
FAQ
- What is Sonoma Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Sonoma Pharmaceuticals?
- What is Sonoma Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Sonoma Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Sonoma Pharmaceuticals?
- What is Sonoma Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Sonoma Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of SNOA is $4.88 M
What is the all time high annual total long term liabilities for Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals all-time high annual total long term liabilities is $5.55 M
What is Sonoma Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, SNOA annual total long term liabilities has changed by +$347.00 K (+7.65%)
What is Sonoma Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of SNOA is $5.02 M
What is the all time high quarterly long term liabilities for Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals all-time high quarterly total long term liabilities is $6.44 M
What is Sonoma Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, SNOA quarterly total long term liabilities has changed by +$172.00 K (+3.54%)